U-Blot® Research Grade Anti-Human CD172a/SIRPA (BR105)Cat. No. WA1336Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD172a/SIRPA (BR105)Cat. No. WA1336
U-Blot® Research Grade Anti-Human CD172a/SIRPA (AL008)Cat. No. WA1335
U-Blot® Research Grade Anti-Human CD171/L1CAM (JCAR023)Cat. No. WA1334
U-Blot® Research Grade Anti-Human CD167a/DDR1 Antibody (Imperial College anti-DDR1)Cat. No. WA1333
U-Blot® Research Grade Anti-Human CD166/ALCAM (AT002)Cat. No. WA1332
U-Blot® Research Grade Anti-Human CD163 (TBI 304H)Cat. No. WA1331
U-Blot® Research Grade Anti-Human CD163 (OR2805)Cat. No. WA1330
U-Blot® Research Grade Anti-Human CD163 (CYMAC-001)Cat. No. WA1329
U-Blot® Research Grade Anti-Human CD162/SELPLG/PSGL-1 (VTX 0811)Cat. No. WA1328
U-Blot® Research Grade Anti-Human CD162/SELPLG/PSGL-1 (AbGn-268)Cat. No. WA1327
U-Blot® Research Grade Anti-Human CD160 (MAT 303)Cat. No. WA1326
U-Blot® Research Grade Anti-Human CD160 (MAT 302)Cat. No. WA1325